Corporate Partnerships Duchenne UK has demonstrated success securing corporate partnerships and family led fundraising, creating a platform to expand sponsorship programs, cause marketing campaigns, and employee engagement initiatives.

Grant Investment The charity awarded £500,000 to develop a DMD therapy in 2025 and has run joint funding calls with other organizations, showing a strong grant making capability that is attractive to research funders and potential grant management vendors.

Digital Fundraising A modern tech stack with a public app launched in 2022 and ongoing web presence indicates readiness for digital fundraising optimization, donor management, and multi channel campaigns; opportunities for platforms that integrate with Microsoft 365, CRM, analytics, and mobile engagement.

Global Collaboration Past collaborations such as the 2022 Joint Call with PPMD and partnerships with SMA UK show openness to international research coalitions; this creates potential for international donor programs, joint grant management, and partnerships with biotech firms to accelerate treatments.

Growth Opportunities With a UK focus, revenue between one and ten million, and a small staff of 11 to 50, Duchenne UK can benefit from targeted vendor services that scale with fundraising campaigns, grant administration, and donor analytics; proposals could include CRM optimization, fundraising campaign management, and cloud based security and data services.